Les infiltrations de corticoïdes perturbent les explorations de l'axe corticotrope

Autor: MF Marquignon, C Tavernier, S. Aho, JM Petit, T. Peere, C. Chatard, Jean-Francis Maillefert, M. C. Huguenin

Publikováno v: La Revue de Médecine Interne. 14:1060

We explored the pituitary-adrenal axis and the morning glycemia before, and 2, 7 and 21 days after a perithecal (9 patients) or intraarticular (2 patients) steroid administration. A short suppression of the pituitary-adrenal axis was observed, while

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e12e65ab57ce65f95c5d164941c71017
https://doi.org/10.1016/s0248-8663(05)80175-4

[Experimental chemotherapy of peritoneal carcinomatosis of colonic origin in rats]

Autor: Chauffert B, Marie-Thérèse Dimanche-Boitrel, Genne P, Jm, Petit, Onier N, Jf, Jeannin

Publikováno v: Europe PubMed Central

Animal models are useful in the evaluation of adjuvant or palliative treatment modalities of human colonic adenocarcinoma. In the present paper, the efficacy of 22 usual chemotherapeutic agents was evaluated in a model of peritoneal carcinomatosis of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::63556d0d153ad7437304efc9cb5f35fe
http://europepmc.org/abstract/med/1582536

Update on Neoadjuvant and Adjuvant BRAF Inhibitors in Papillary Craniopharyngioma: A Systematic Review.

Autor: Cossu G; Department of Neurosurgery, University Hospital of Lausanne and University of Lausanne, 1011 Lausanne, Switzerland.; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Ramsay DSC; Imperial Brain and Spine Initiative, London W2 1NY, UK.; Imperial College School of Medicine, London W2 1PG, UK., Daniel RT; Department of Neurosurgery, University Hospital of Lausanne and University of Lausanne, 1011 Lausanne, Switzerland., El Cadhi A; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Kerherve L; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Morlaix E; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Houidi SA; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Millot-Piccoli C; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Chapon R; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Le Van T; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Cao C; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Farah W; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Lleu M; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Baland O; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Beaurain J; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Petit JM; Department of Endocrinology, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Lemogne B; Department of Neuroradiology, University Hospital of Dijon Bourgogne, 21000 Dijon, France., Messerer M; Department of Neurosurgery, University Hospital of Lausanne and University of Lausanne, 1011 Lausanne, Switzerland., Berhouma M; Department of Neurosurgery, University Hospital of Dijon Bourgogne, 21000 Dijon, France.; Functional and Molecular Imaging Team (CNRS 6302), Molecular Chemistry Institute (ICMUB), University of Burgundy, 21078 Dijon, France.

Publikováno v: Cancers [Cancers (Basel)] 2024 Oct 14; Vol. 16 (20). Date of Electronic Publication: 2024 Oct 14.

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Autor: Denimal D; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 2 rue Ducoudray, F-21079 Dijon, France. Electronic address: damien.denimal@u-bourgogne.fr., Duvillard L; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Clinical Biochemistry, Dijon Bourgogne University Hospital, 2 rue Ducoudray, F-21079 Dijon, France., Béland-Bonenfant S; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Terriat B; Department of Angiology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21079 Dijon, France., Pais-de-Barros JP; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; DiviOmics Platform, UMS BIOSAND, University of Burgundy, F-21000 Dijon, France., Simoneau I; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Rouland A; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Houbachi L; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Bouillet B; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Vergès B; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France., Petit JM; INSERM Unit 1231, Faculty of Health Sciences - University of Burgundy, 3 Bd Lattre de Tassigny, F-21000 Dijon, France; Department of Endocrinology and Diabetology, Dijon Bourgogne University Hospital, 2 Bd Maréchal Lattre de Tassigny, F-21000 Dijon, France.

Publikováno v: Diabetes & metabolism [Diabetes Metab] 2024 Jul; Vol. 50 (4), pp. 101542. Date of Electronic Publication: 2024 May 04.

Reply: Concerns regarding the use of Fatty Liver Index in studies of lean NAFLD.

Autor: Nabi O; Washington University in St Louis School of Medicine, Saint Louis, Missouri, USA.; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France., Lapidus N; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France., Boursier J; Hepatogastroenterology Department, Anger University Hospital, Angers, France.; HIFIH Laboratory, UPRES EA3859, SFR 4208, Angers University, Angers, France., de Ledinghen V; Bordeaux University Hospital Branch, Bordeaux, France., Petit JM; Department of Endocrinology-Diabetology, Dijon University Hospital, Dijon, France., Kab S; Versailles-Saint Quentin University, UMS 11 Inserm, France., Renuy A; Versailles-Saint Quentin University, UMS 11 Inserm, France., Zins M; Versailles-Saint Quentin University, UMS 11 Inserm, France.; Université de Paris, Paris, France., Lacombe K; Sorbonne University, Inserm, Pierre Louis Institute of Epidemiology and Public Health (IPLESP), AP-HP, Saint-Antoine Hospital, Paris, France.; Infectious Diseases Department, Hôpital Saint-Antoine, AP-HP, Paris, France., Serfaty L; Hepatogastroenterology Service, Hôpital Hautepierre, Strasbourg University Hospital, France.; Sorbonne University, Inserm UMR_S938, Paris, France.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 May 01; Vol. 79 (5), pp. E130-E131. Date of Electronic Publication: 2024 Jan 22.